EU Law and International Clinical Trials: Towards Strengthened Protections for Research Subjects
From Elisabeth Barlow
Clinical trials are essential to the production and licensing of pharmaceuticals on the basis that they are both safe and efficacious. This lunchtime seminar outlined how the EU actively facilitates the use of clinical trials data produced in the global South for the production and authorisation of pharmaceuticals in its internal market and highlights some of the ethical implications for those enrolled in the trials (the research subjects).
About the Speakers
Dr Mark Flear (Queen's University Belfast) and Mr Gerard Porter (University of Edinburgh)